Image 1 of 1
Image 1 of 1
Image 1 of 1
Image 1 of 1
A GLP-1 receptor agonist that helps regulate appetite and blood sugar levels. It promotes satiety and reduces cravings, making it an effective tool for weight loss and blood sugar management.
Semaglutide and Obesity - Semaglutide, a GLP-1 receptor agonist, significantly reduces body weight by enhancing satiety and reducing appetite in obese patients. A 2021 trial showed an average 14.9% weight loss over 68 weeks, alongside improved cardiometabolic markers
A GLP-1 receptor agonist that helps regulate appetite and blood sugar levels. It promotes satiety and reduces cravings, making it an effective tool for weight loss and blood sugar management.
Semaglutide and Obesity - Semaglutide, a GLP-1 receptor agonist, significantly reduces body weight by enhancing satiety and reducing appetite in obese patients. A 2021 trial showed an average 14.9% weight loss over 68 weeks, alongside improved cardiometabolic markers